Envision Healthcare (EVHC) Shares Sold by Prudential Financial Inc

Envision Healthcare (EVHC) Shares Sold by Prudential Financial Inc

Cantor Fitzgerald maintained the stock with "Hold" rating in Monday, May 7 report. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the stock. Rampart Investment Management Company LLC increased its position in shares of Envision Healthcare by 124.4% during the first quarter. The stock of Envision Healthcare Corporation (NYSE:EVHC) earned "Buy" rating by SunTrust on Wednesday, December 20. Ten analysts have made estimates for Envision Healthcare's earnings, with estimates ranging from $2.07 billion to $2.11 billion. Boston Partners grew its stake in Envision Healthcare by 362.0% in the 1st quarter. Finally, Alps Advisors Inc. purchased a new stake in Envision Healthcare in the fourth quarter worth about $235,000. SG Americas Securities LLC now owns 22,455 shares of the company's stock worth $776,000 after acquiring an additional 17,286 shares during the period. State Treasurer State of MI now owns 38,600 shares of the company's stock valued at $2,367,000 after buying an additional 200 shares in the last quarter. Envision Healthcare has $50.0 highest and $34.0 lowest target.

Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings data on Monday, May 7th. Jefferies Financial Group set a $46.00 target price on shares of Envision Healthcare and gave the company a "buy" rating in a research note on Wednesday, April 11th. Cantor Fitzgerald reaffirmed a "hold" rating and issued a $37.00 price objective on shares of Envision Healthcare in a research report on Wednesday, February 21st. LLC bought a new position in shares of Envision Healthcare during the 1st quarter worth about $2,304,000.

Pursuant to the closing of the deal, Envision shares will be delisted from the NYSE, as it will be cease to be a public company. The stock presently has a consensus rating of "Hold" and an average target price of $41.10. Canaccord Genuity boosted their price objective on shares of Envision Healthcare from $46.00 to $48.00 and gave the company a "buy" rating in a report on Wednesday, May 9th. The stock has a market cap of $5.29 billion, a P/E ratio of 18.00, a P/E/G ratio of 0.99 and a beta of 0.46. The company was maintained on Wednesday, March 7 by Robert W. Baird. They expect $0.80 earnings per share, up 1.27 % or $0.01 from last year's $0.79 per share. The stock was sold at an average price of $65.00, for a total value of $97,500.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 2.30% of the company's stock.

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The firm operates through three reportable divisions: Physician Services, Medical Transportation, and Ambulatory Services. Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC?

Related Articles